Pathogen Solution Marketplace

Project Synopsis

The Pathogen Solution Marketplace is a specialised platform connecting AMR solution developers directly with targeted funders. It creates a streamlined channel between breakthrough research and the capital needed to bring it to market. Built on community-driven prioritisation, it addresses the core paradox of AMR: the most urgently needed solutions are often the least commercially viable under traditional models.

Project team

No items found.

Where urgent health needs meet smart investment.

The pathogens that most threaten global health often offer the weakest commercial incentives. Our marketplace transforms this challenge by creating a platform where researchers can showcase promising solutions targeting specific pathogens while investors discover opportunities aligned with their risk profiles and impact goals.

When launched, the marketplace will operate with standardised evaluation criteria and transparent economic forecasts. Prioritisation decisions are guided by data-driven assessment of which pathogens represent the most urgent threats, balancing the need for equitable solutions with promising investment opportunities.

"By 2050, AMR could slash global GDP by nearly 4%, yet investments in AMR solutions remain deeply underwhelming. We're changing that."

Bridging the gap between scientific innovation and investment capital

How It Works

Researchers showcase breakthrough AMR solutions and request targeted funding. Investors filter opportunities by economic impact potential. Policymakers identify critical gaps in our antimicrobial arsenal. The global community collectively directs resources to the most pressing resistance threats, serving underserved populations.

Vision

This marketplace serves as the central valuation mechanism, transforming scientific potential into financial terms that drive investment decisions while ensuring resources flow to pathogens where new solutions can create the greatest impact.

Conclusion

Together, we're not just funding individual AMR solutions; we are creating a new paradigm for antimicrobial investment that aligns economic incentives with public health imperatives. The Pathogen Solution Marketplace represents how we move from fragmentation to focus, from isolated efforts to aligned action, building a more resilient future in the face of antimicrobial resistance, one calculated investment at a time.